|
|
|
|
|
Cosmetic preservative labelling on the Thai market |
2559 |
# |
|
|
|
|
|
Cost effectiveness analysis of an initial ICU admission as compared to a delayed ICU admission in patients with severe sepsis or in septic shock |
2557 |
# |
|
|
|
|
|
Cost effectiveness of combined CT pulmonary angiography (CTPA) and indirect CTV in patient with intermediate to high probability for pulmonary embolism |
2555 |
# |
|
|
|
|
|
Cost of Dengue Cases in Eight Countries in the Americas and Asia: A Prospective Study |
2552 |
# |
|
|
|
|
|
Cost-effectiveness Analysis and Safety of Erythromycin 4%Gel and 4% Chlorhexidine Scrub for Pitted Keratolysis Treatment. |
2561 |
# |
|
|
|
|
|
Cost-effectiveness analysis in comparing alginate silver dressing with silver zinc sulfadiazine cream in the treatment of pressure ulcers |
2556 |
# |
|
|
|
|
|
Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis. |
2556 |
# |
|
|
|
|
|
Cost-effectiveness analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj Hospital, Thailand |
2549 |
# |
|
|
|
|
|
Cost-effectiveness analysis of highly concentrated n-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction |
2558 |
# |
|
|
|
|
|
Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation |
2562 |
# |
|
|
|
|
|
COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON ALFA-2A (40 KD) PLUS RIBAVIRIN VERSUS NO TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C (CHC), GENOTYPE 1 FROM A PAYER PERSPECTIVE IN THAILAND |
2552 |
# |
|
|
|
|
|
Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand |
2561 |
# |
|
|
|
|
|
Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction. |
2562 |
# |
|
|
|
|
|
Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients. |
2560 |
# |
|
|
|
|
|
Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand. |
2562 |
# |
|
|
|
|
|
Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn's disease using real world evidence in Thailand |
2563 |
# |
|
|
|
|
|
COST-EFFECTIVENESS OF ANTIDEPRESSANT AFTER 24 MONTHS OF TREATMENT BASED ON DISCRETE EVENT SIMULATION MODELING (DESM): AGOMELATINE VERSUS MATRIX COMPARATOR OF ESCITALOPRAM, SERTRALINE AND VENLAFAXINE IN A THAI SETTING |
2556 |
# |
|
|
|
|
|
COST-EFFECTIVENESS OF ATORVASTATIN VERSUS SIMVASTATIN IN PREVENTION OF CARDIOVASCULAR EVENTS FROM A THAILAND SOCIETAL PERSPECTIVE |
2564 |
# |
|
|
|
|
|
Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand |
2563 |
# |
|
|
|
|
|
Cost-effectiveness of thoracic patient-controlled epidural analgesia using bupivacaine with fentanyl vs bupivacaine with morphine after thoracotomy and upper abdominal surgery. |
2548 |
# |
|
|
|
|
|
Cost-saving Minimal Incision Endoscopic-assisted Cubital Tunnel Release Using Simple Surgical Instruments: Case Series |
2562 |
# |
|
|
|
|
|
Cost-Utility Analysis Compared Between Radiotherapy Alone and Combined Surgery and Radiotherapy for Symptomatic Spinal Metastases in Thailand |
2565 |
# |
|
|
|
|
|
Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction |
2564 |
# |
|
|
|
|
|
Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand. |
2558 |
# |
|
|
|
|
|
Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction |
2565 |
# |
|
|
|
|
|
Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai End-Stage Renal Disease Patients |
2563 |
# |
|
|
|
|
|
Cost-Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand |
2564 |
# |
|
|
|
|
|
Cost-Utility Analysis of Erythropoietin for Anemia Treatment in Thai End-Stage Renal Disease Patients with Hemodialysis |
2557 |
# |
|
|
|
|
|
COST-UTILITY ANALYSIS OF HERPES ZOSTER VACCINE IN THAILAND |
2560 |
# |
|
|
|
|
|
COST-UTILITY ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT IN THAILAND. |
2561 |
# |